What is Rancho Tissue Technologies?
Rancho Tissue Technologies operates as a premier provider of tissue-cultured and custom-propagated plant varieties, serving both the agricultural and horticultural industries. With a robust annual production capacity of 5 million units, the company utilizes state-of-the-art greenhouse and laboratory facilities to ensure the delivery of vigorous, pathogen-free crops. Founded by Heather Hunter May, the organization has spent nearly four decades refining its specialized propagation techniques. Beyond its commercial operations, the company maintains a critical role in the agricultural ecosystem as a member of the USDA Germplasm Resources Information Network, actively contributing to the preservation and propagation of essential agricultural crop varieties.
How much funding has Rancho Tissue Technologies raised?
Rancho Tissue Technologies has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Rancho Tissue Technologies
PPP
Public-Private Partnership
What's next for Rancho Tissue Technologies?
With this recent capital, Rancho Tissue Technologies is positioned to accelerate its operational footprint and enhance its research and development capabilities. The strategic focus will likely center on expanding its portfolio of medicinal and food crops, further cementing its status as a leader in plant biotechnology. By optimizing its laboratory throughput and exploring new market segments, the company is well-equipped to address the increasing complexities of modern agriculture. Future growth will be driven by the firm's commitment to innovation in tissue culture, ensuring that it remains a vital partner for large-scale agricultural producers seeking reliable, high-yield plant solutions.
See full Rancho Tissue Technologies company page
